Ching‐Chan Lin

701 total citations
32 papers, 481 citations indexed

About

Ching‐Chan Lin is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ching‐Chan Lin has authored 32 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Surgery. Recurrent topics in Ching‐Chan Lin's work include Head and Neck Cancer Studies (5 papers), Peptidase Inhibition and Analysis (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Ching‐Chan Lin is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Peptidase Inhibition and Analysis (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Ching‐Chan Lin collaborates with scholars based in Taiwan, China and United States. Ching‐Chan Lin's co-authors include Ching-Yun Hsieh, Su‐Peng Yeh, Chen‐Yuan Lin, Li‐Yuan Bai, Wei‐Chao Chang, Chang‐Fang Chiu, Yuh‐Pyng Sher, Chi‐Rei Yang, Chi‐Ping Huang and Chang-Fang Chiu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Applied Soft Computing.

In The Last Decade

Ching‐Chan Lin

32 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐Chan Lin Taiwan 13 203 135 105 92 88 32 481
Giammarco Surico Italy 11 99 0.5× 191 1.4× 66 0.6× 97 1.1× 59 0.7× 27 480
Geoffroy Venton France 13 147 0.7× 116 0.9× 69 0.7× 191 2.1× 52 0.6× 53 497
Christine‐Ivy Liacos Greece 12 178 0.9× 91 0.7× 71 0.7× 94 1.0× 39 0.4× 33 509
Colette Chapuis‐Cellier France 15 150 0.7× 157 1.2× 145 1.4× 100 1.1× 41 0.5× 40 604
Vladimir Vainstein Israel 15 226 1.1× 283 2.1× 60 0.6× 236 2.6× 53 0.6× 51 723
Andrea Kerkhoff Germany 14 93 0.5× 360 2.7× 85 0.8× 57 0.6× 119 1.4× 33 578
Jess F. Peterson United States 15 205 1.0× 101 0.7× 72 0.7× 228 2.5× 36 0.4× 83 584
Anupam Sarma India 12 206 1.0× 152 1.1× 119 1.1× 28 0.3× 110 1.3× 61 567
Maik Häntschel Germany 12 231 1.1× 253 1.9× 94 0.9× 55 0.6× 193 2.2× 21 684
Adarsh Joshi United States 10 188 0.9× 170 1.3× 88 0.8× 29 0.3× 119 1.4× 19 633

Countries citing papers authored by Ching‐Chan Lin

Since Specialization
Citations

This map shows the geographic impact of Ching‐Chan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Chan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Chan Lin more than expected).

Fields of papers citing papers by Ching‐Chan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Chan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Chan Lin. The network helps show where Ching‐Chan Lin may publish in the future.

Co-authorship network of co-authors of Ching‐Chan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Chan Lin. A scholar is included among the top collaborators of Ching‐Chan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Chan Lin. Ching‐Chan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Nai‐Jung, Li-Yuan Bai, Chang‐Fang Chiu, et al.. (2025). A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumors. Investigational New Drugs. 43(3). 709–718. 1 indexed citations
2.
Lin, Ching‐Chan, Wen-Jyi Lo, Ching-Yun Hsieh, et al.. (2024). Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia. Cancers. 16(6). 1082–1082. 2 indexed citations
3.
Huang, Yukai, Wei‐Chung Cheng, Juan‐Cheng Yang, et al.. (2024). Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy. Nature Cancer. 5(3). 400–419. 14 indexed citations
4.
Lin, Ching‐Chan, et al.. (2024). Deep learning assists in acute leukemia detection and cell classification via flow cytometry using the acute leukemia orientation tube. Scientific Reports. 14(1). 8350–8350. 13 indexed citations
5.
Yeh, Chun‐Chieh, Ching‐Chan Lin, Chih‐Hua Chao, et al.. (2023). Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment. Molecular Oncology. 17(8). 1648–1665. 5 indexed citations
6.
Hsieh, Ching-Yun, Ching‐Chan Lin, & Wei‐Chao Chang. (2023). Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma. Biomedicines. 11(11). 2887–2887. 7 indexed citations
7.
Chen, Tzu‐Ting, Ching‐Chan Lin, Wen-Jyi Lo, et al.. (2022). Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies. International Journal of Hematology. 115(4). 525–533. 8 indexed citations
8.
Chen, Tzu‐Ting, et al.. (2022). High rate of invasive fungal infections during early cycles of azacitidine for patients with acute myeloid leukemia. Frontiers in Cellular and Infection Microbiology. 12. 1012334–1012334. 9 indexed citations
9.
Hsieh, Ching-Yun, Ching‐Chan Lin, Yu-Wen Huang, et al.. (2022). Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling. JCI Insight. 7(23). 35 indexed citations
10.
11.
Lin, Ching‐Chan, Yukai Huang, Wei‐Chung Cheng, et al.. (2020). Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression. Theranostics. 10(24). 10925–10939. 26 indexed citations
12.
Hsieh, Ching-Yun, et al.. (2020). Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study. BMC Cancer. 20(1). 832–832. 16 indexed citations
13.
14.
Chen, Ming, Long‐Yuan Li, Su‐Peng Yeh, et al.. (2017). A targeted next‐generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice. Cancer Medicine. 6(2). 349–360. 43 indexed citations
15.
Lin, Shih-Yi, Chao-Hsiang Chang, Ching‐Chan Lin, et al.. (2016). Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma. Scientific Reports. 6(1). 34446–34446. 64 indexed citations
16.
Hsieh, Te‐Chun, et al.. (2015). Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT. Clinical Nuclear Medicine. 41(1). 86–87. 7 indexed citations
17.
Hsieh, Te‐Chun, Tse-Yen Yang, Lin Chen, et al.. (2015). [18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma. The Oncologist. 20(5). 539–545. 9 indexed citations
18.
Chen, Tzu-Ting, Chang-Fang Chiu, Tse-Yen Yang, et al.. (2014). Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy. Leukemia Research. 39(2). 151–156. 13 indexed citations
19.
Yeh, Su-Peng, Ching-Yun Hsieh, Li-Yuan Bai, et al.. (2013). Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation. Supportive Care in Cancer. 22(5). 1199–1206. 4 indexed citations
20.
Lin, Po‐Han, Ching‐Chan Lin, Hwai‐I Yang, et al.. (2012). Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3. Leukemia Research. 37(3). 287–292. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giammarco Surico Breakdown of academic impact, for papers by Geoffroy Venton Breakdown of academic impact, for papers by Christine‐Ivy Liacos Breakdown of academic impact, for papers by Colette Chapuis‐Cellier Breakdown of academic impact, for papers by Vladimir Vainstein Breakdown of academic impact, for papers by Andrea Kerkhoff Breakdown of academic impact, for papers by Jess F. Peterson Breakdown of academic impact, for papers by Anupam Sarma Breakdown of academic impact, for papers by Maik Häntschel Breakdown of academic impact, for papers by Adarsh Joshi
Rankless by CCL
2026